Pyrazolo-quinazoline derivatives of formula (Ia) or (Ib) as defined in thespecification, and pharmaceutically acceptable salts thereof, process fortheir preparation and pharmaceutical compositions comprising them aredisclosed； the compounds of the invention may be useful, in therapy, in thetreatment of diseases associated with a disregulated protein kinase activity,like cancer.
